Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$379.52|
|52 Week High||US$244.10|
|52 Week Low||US$406.00|
|1 Month Change||0.40%|
|3 Month Change||0.83%|
|1 Year Change||43.65%|
|3 Year Change||39.26%|
|5 Year Change||199.87%|
|Change since IPO||1,755.84%|
Recent News & Updates
Is Now An Opportune Moment To Examine Anthem, Inc. (NYSE:ANTM)?
Today we're going to take a look at the well-established Anthem, Inc. ( NYSE:ANTM ). The company's stock received a lot...
UnitedHealth Vs. Anthem: A Quantitative 5-Year Outlook
This is a quantitative study and doesn't cover recent idiosyncratic events. Pricing metrics, Valuation metrics, and Backtesting are applied. Dividends are analyzed ex-post and ex-ante. Find out which is the better investment for the next 5 years! Any value-added debate is welcomed. Happy Investing!
Anthem's (NYSE:ANTM) Returns Have Hit A Wall
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
|ANTM||US Healthcare||US Market|
Return vs Industry: ANTM exceeded the US Healthcare industry which returned 33% over the past year.
Return vs Market: ANTM exceeded the US Market which returned 33.8% over the past year.
Stable Share Price: ANTM is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ANTM's weekly volatility (3%) has been stable over the past year.
About the Company
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Anthem Fundamentals Summary
|ANTM fundamental statistics|
Is ANTM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ANTM income statement (TTM)|
|Cost of Revenue||US$95.47b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Oct 20, 2021
|Earnings per share (EPS)||17.13|
|Net Profit Margin||3.27%|
How did ANTM perform over the long term?See historical performance and comparison
1.2%Current Dividend Yield
Is Anthem undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ANTM ($379.52) is trading below our estimate of fair value ($770.72)
Significantly Below Fair Value: ANTM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ANTM is good value based on its PE Ratio (21.9x) compared to the US Healthcare industry average (22.6x).
PE vs Market: ANTM is poor value based on its PE Ratio (21.9x) compared to the US market (17.8x).
Price to Earnings Growth Ratio
PEG Ratio: ANTM is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: ANTM is good value based on its PB Ratio (2.6x) compared to the US Healthcare industry average (3.4x).
How is Anthem forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANTM's forecast earnings growth (9.5% per year) is above the savings rate (2%).
Earnings vs Market: ANTM's earnings (9.5% per year) are forecast to grow slower than the US market (14.8% per year).
High Growth Earnings: ANTM's earnings are forecast to grow, but not significantly.
Revenue vs Market: ANTM's revenue (7.7% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: ANTM's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ANTM's Return on Equity is forecast to be low in 3 years time (18.5%).
How has Anthem performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANTM has high quality earnings.
Growing Profit Margin: ANTM's current net profit margins (3.3%) are lower than last year (5.2%).
Past Earnings Growth Analysis
Earnings Trend: ANTM's earnings have grown by 13.7% per year over the past 5 years.
Accelerating Growth: ANTM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ANTM had negative earnings growth (-28.5%) over the past year, making it difficult to compare to the Healthcare industry average (32.2%).
Return on Equity
High ROE: ANTM's Return on Equity (12.1%) is considered low.
How is Anthem's financial position?
Financial Position Analysis
Short Term Liabilities: ANTM's short term assets ($50.2B) exceed its short term liabilities ($33.8B).
Long Term Liabilities: ANTM's short term assets ($50.2B) exceed its long term liabilities ($27.3B).
Debt to Equity History and Analysis
Debt Level: ANTM's debt to equity ratio (66.3%) is considered high.
Reducing Debt: ANTM's debt to equity ratio has reduced from 70.5% to 66.3% over the past 5 years.
Debt Coverage: ANTM's debt is well covered by operating cash flow (29.5%).
Interest Coverage: ANTM's interest payments on its debt are well covered by EBIT (9.6x coverage).
What is Anthem current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ANTM's dividend (1.19%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: ANTM's dividend (1.19%) is low compared to the top 25% of dividend payers in the US market (3.6%).
Stability and Growth of Payments
Stable Dividend: ANTM's dividends per share have been stable in the past 10 years.
Growing Dividend: ANTM's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (24.3%), ANTM's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ANTM's dividends in 3 years are forecast to be well covered by earnings (18% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gail Boudreaux (60 yo)
Ms. Gail Koziara Boudreaux has been President, Chief Executive Officer and Director of Anthem, Inc. since November 11, 2017. Prior to joining the Company, she served as Chief Executive Officer of GKB Globa...
CEO Compensation Analysis
Compensation vs Market: Gail's total compensation ($USD17.11M) is above average for companies of similar size in the US market ($USD11.33M).
Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.
Experienced Management: ANTM's management team is seasoned and experienced (5.5 years average tenure).
Experienced Board: ANTM's board of directors are considered experienced (8.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ANTM insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Anthem, Inc.'s employee growth, exchange listings and data sources
- Name: Anthem, Inc.
- Ticker: ANTM
- Exchange: NYSE
- Founded: 1944
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$92.533b
- Shares outstanding: 243.82m
- Website: https://www.antheminc.com
Number of Employees
- Anthem, Inc.
- 220 Virginia Avenue
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/19 22:09|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.